Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4

Dapito, Dianne H., Mencin, Ali, Gwak, Geum-Youn, Pradere, Jean-Philippe, Jang, Myoung-Kuk, Mederacke, Ingmar, Caviglia, Jorge M., Khiabanian, Hossein +8 more·2012·Cancer Cell

DOI 10.1016/j.ccr.2012.02.007

Cited by (1,000)

Items 701–800 of 1,000

Microbiome interplays in the gut-liver axis: implications for liver cancer pathogenesis and therapeutic insights
Xuran Wang, Bin Zhang, Runqiu Jiang · 2025 · Frontiers in Cellular and Infection Microbiology
Three Measurable and Modifiable Enteric Microbial Biotransformations Relevant to Cancer Prevention and Treatment
Gregory Adams Plotnikoff · 2014 · Global Advances in Health and Medicine
Annona senegalensis extract demonstrates anticancer properties in N-diethylnitrosamine-induced hepatocellular carcinoma in male Wistar rats
Omolara Faith Yakubu, Damilohun Samuel Metibemu, Isaacson B. Adelani, Gbolahan O. Adesina, Chidera B. Edokwe, Oyinkansola E. Oseha, Abiodun Humphrey Adebayo · 2020 · Biomedicine & Pharmacotherapy
NAFLD-related HCC.
B. Banini, A. Sanyal · 2021 · Advances in Cancer Research
Molecular Immune Mechanism of Intestinal Microbiota and Their Metabolites in the Occurrence and Development of Liver Cancer
Chenchen Bi, Geqiong Xiao, Chunyan Liu, Junwei Yan, Jiaqi Chen, Wenzhang Si, Jian Zhang, Zheng Liu · 2021 · Frontiers in Cell and Developmental Biology
Association between gut microbiota and hepatocellular carcinoma from 2011 to 2022: Bibliometric analysis and global trends
Zhitao Chen, Chenchen Ding, Yangjun Gu, Yahui He, Bing Y. Chen, Shusen Zheng, Qiyong Li · 2023 · Frontiers in Oncology
Gut microbial signatures of patients with primary hepatocellular carcinoma and their healthy first-degree relatives
Jing Feng, Yalin Wu, Peng Dai, Dong Wang, Lixin Liu, Baofeng Chai · 2023 · Journal of Applied Microbiology
RPLP2 activates TLR4 in an autocrine manner and promotes HIF-1α-induced metabolic reprogramming in hepatocellular carcinoma
Qingqing Yang, Xiangrui Meng, Jin Chen, Xiangsu Li, Yang Huang, Xueyi Xiao, Rongqing Li, Xudong Wu · 2023 · Cell Death Discovery
Can non-selective beta-blockers prevent hepatocellular carcinoma in patients with cirrhosis?
Maja Sofie Thiele, Reiner Wiest, Lise Lotte Gluud, Agustı́n Albillos, Aleksander Ahm Krag · 2013 · Medical Hypotheses
Interaction of PTPRO and TLR4 signaling in hepatocellular carcinoma
Donghua Xu, Xiaochen Wang, Shushan Yan, Yin Yin, Jiajie Hou, Xuehao Wang, Beicheng Sun · 2014 · Tumor Biology
TLR7 agonist induced repression of hepatocellular carcinoma via the TLR7-IKK-NF-κB-IL6 signaling pathway
Xingbin Ren, Fei Wang, Baoju Ji, Chunhai Gao · 2016 · Oncology Letters
Hepatocellular carcinoma in patients with HIV
Imane El Dika, James J. Harding, Ghassan K. Abou‐Alfa · 2016 · Current Opinion in HIV and AIDS
Omics for Understanding the Gut‐Liver‐Microbiome Axis and Precision Medicine
Jag H. Khalsa, Linda C. Duffy, Gabriela Riscuta, Pamela E Starke-Reed, Van S. Hubbard · 2017 · Clinical Pharmacology in Drug Development
Prebiotics: A Novel Approach to Treat Hepatocellular Carcinoma
Naz Fatima, Tasleem Akhtar, Nadeem Sheikh · 2017 · Canadian Journal of Gastroenterology and Hepatology
Donor Polymorphisms of Toll-like Receptor 4 rs1927914 Associated with the Risk of Hepatocellular Carcinoma Recurrence Following Liver Transplantation
Guangjun Shi, Chuanxu Wang, Ping Zhang, Lisha Ji, Shifeng Xu, Xueying Tan, Hao Li · 2017 · Archives of Medical Research
Elevated epiregulin expression predicts poor prognosis in gastric cancer
Qiuyan Xia, Yan Zhou, Hongmei Yong, Xudong Wang, Wei Zhao, Guipeng Ding, Jin Zhu, Xiaohua Li, Zhenqing Feng, Bing Wang · 2019 · Pathology - Research and Practice
Chenopodium Quinoa and Salvia Hispanica Provide Immunonutritional Agonists to Ameliorate Hepatocarcinoma Severity under a High-Fat Diet
José Moisés Laparra, Daniel Brown, Blanca Saiz · 2020 · Nutrients
Characterizing the mechanism behind the progression of NAFLD to hepatocellular carcinoma
P. Nahon, M. Allaire, J. Nault, V. Paradis · 2020 · Hepatic Oncology
Lipopolysaccharide promotes cancer cell migration and invasion through METTL3/PI3K/AKT signaling in human cholangiocarcinoma
Jing Ke, C. Zhang, Lianzi Wang, Feng-shuo Xie, Hongyu Wu, Tao Li, Congwen Bian, Ruolin Wu · 2024 · Heliyon
Macrophages Orchestrate the Liver Tumor Microenvironment
Valeria Quaranta, Costanza Ballarò, Gianluigi Giannelli · 2024 · Cancers
Enterococcal-host interactions in the gastrointestinal tract and beyond
Wiam Abdalla Mohammed Madani, Yusibeska Ramos, Juan R. Cubillos‐Ruiz, Diana K. Morales · 2024 · FEMS Microbes
Impact of gut microbiota on metabolic dysfunction-associated steatohepatitis and hepatocellular carcinoma: pathways, diagnostic opportunities and therapeutic advances
Ayana R. Kumar, Bhagyalakshmi Nair, Adithya Jayaprakash Kamath, Lekshmi R. Nath, Daniela Cornelia Călina, Javad Sharifi‐Rad · 2024 · European journal of medical research
TLR/WNT: A Novel Relationship in Immunomodulation of Lung Cancer
Aina Martín-Medina, Noemi Cerón-Pisa, Esther Martinez-Font, Hanaa Shafiek, Antònia Obrador‐Hevia, Jaume Sauleda, Amanda Iglesias · 2022 · International Journal of Molecular Sciences
Dysbiosis: The first hit for digestive system cancer
Si Mei, Zhe Deng, Yating Chen, Di-Min Ning, Yinmei Guo, Xing‐Xing Fan, Ruoyu Wang, Yuelin Meng, Qing Zhou, Xuefei Tian · 2022 · Frontiers in Physiology
Microbiota-Derived Natural Products Targeting Cancer Stem Cells: Inside the Gut Pharma Factory
Valentina Artusa, Luana Calabrone, Lorenzo Mortara, Francesco Peri, Antonino Bruno · 2023 · International Journal of Molecular Sciences
TLR4 Targeting: A Promising Therapeutic Approach Across Multiple Human Diseases
Sakshi Kumar, Vikram Sharma, Shikha Yadav · 2024 · Current Protein and Peptide Science
Novel chemokine-like activities of histones in tumor metastasis
Ruochan Chen, Yangchun Xie, Xiao Yan Zhong, Yongmin Fu, Yan Huang, Yixiang Zhen, Pinhua Pan, Haichao Wang, David L. Bartlett, Timothy R. Billiar et al. · 2016 · Oncotarget
Microbiote intestinal et réponses aux thérapies anti-tumorales
Marie Vétizou, Romain Daillère, Laurence Zitvogel · 2016 · médecine/sciences
TLR4 Influences Hepatitis B Virus Related Hepatocellular Carcinoma by Regulating the Wnt/β-Catenin Pathway
Yuanqin Yin, Fei Li, Song‐Lin Li, Jingjing Cai, Jing Shi, Youhong Jiang · 2017 · Cellular Physiology and Biochemistry
Microbiota, Liver Diseases, and Alcohol
Anne‐Marie Cassard, Philippe Gérard, Gabriel Perlemuter · 2017 · Microbiology Spectrum
Ciprofloxacin promotes polarization of CD86+CD206‑ macrophages to suppress liver cancer
Mengtian Fan, Sicheng Chen, Yaguang Weng, Xian Li, Yingjiu Jiang, Xiaowen Wang, Mengjun Bie, Liqin An, Menghao Zhang, Bin Chen et al. · 2020 · Oncology Reports
Yin and yang of tumor inflammation: How innate immune suppressors shape the tumor microenvironments
Masahisa Jinushi · 2013 · International Journal of Cancer
Alterations in the gastric microbiota and metabolites in gastric cancer: An update review
Lei, Changzhen, Gong, Daojun, Zhuang, Bo, Zhang, Zhiwei · 2022 · Frontiers in Oncology
A systematic review on multipotent carcinogenic agent, N‐nitrosodiethylamine (NDEA), its major risk assessment, and precautions
Pracheta Janmeda, Divya Jain, Priya Chaudhary, Mukesh Meena, Devendra Singh · 2024 · Journal of Applied Toxicology
Toll-Like Receptors (TLRs) in the Tumor Microenvironment (TME): A Dragon-Like Weapon in a Non-fantasy Game of Thrones
Mahmud Angrini, Aditi Varthaman, Isabelle Cremer · 2020 · Advances in experimental medicine and biology
Targeted delivery of miR-218 via decorated hyperbranched polyamidoamine for liver cancer regression
Asmaa M. Elfiky, Rania Hassan Mohamed, Fatma El-Zahraa Abd El-Hakam, Mohamed Abdallah Yassin, Mahmoud ElHefnawi · 2021 · International Journal of Pharmaceutics
Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma
Edda Russo, Camila Fiorindi, Francesco Giudici, Amedeo Amedei · 2022 · World Journal of Hepatology
Identification reproducible microbiota biomarkers for the diagnosis of cirrhosis and hepatocellular carcinoma
Huarong Zhang, Junling Wu, Yijuan Liu, Yongbin Zeng, Zhiyu Jiang, Haidan Yan, Jie Lin, Weixin Zhou, Qishui Ou, Lu Ao · 2023 · AMB Express
Forces at play: exploring factors affecting the cancer metastasis
Farooq Riaz, Jing Zhang, Fan Pan · 2024 · Frontiers in Immunology
The innate immune signaling in cancer and cardiometabolic diseases: Friends or foes?
Weijun Wang, Yaxing Zhang, Ling Yang, Hongliang Li · 2016 · Cancer Letters
Toll-like receptor 4: a target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitis
Jennifer L. Nguyen, Jingjing Jiao, Kristin Smoot, Gordon P. Watt, Chen Zhao, Xingzhi Song, Heather L. Stevenson, Joseph B. McCormick, Susan P. Fisher‐Hoch, Jianhua Zhang et al. · 2018 · Oncotarget
Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma
Tareq M. Haedenkamp, Michael Fred Leitzmann, Ralf Andreas Linker, Christoph Rudolf Meier, Claudia Becker, Susan Sara Jick, Katharina Sahm, Michael Platten, Peter Hau, Corinna Seliger · 2019 · Cancer Medicine
Omics‐derived hepatocellular carcinoma risk biomarkers for precision care of chronic liver diseases
Naoto Fujiwara, Tongqi Qian, Bhuvaneswari Koneru, Yujin Hoshida · 2020 · Hepatology Research
32nd Annual Meeting and Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2017): Late-Breaking Abstracts
2017 · Journal for ImmunoTherapy of Cancer
Gut microbiota changes and biological mechanism in hepatocellular carcinoma after transarterial chemoembolization treatment
Chao-fan Bian, Ying Wang, Ao Yu, Lulan Fu, Ding Zhang, Wenzhi Zhu, Wei‐Fu Lv · 2022 · Frontiers in Oncology
Bifidobacterium longum-Derived Extracellular Vesicles Prevent Hepatocellular Carcinoma by Modulating the TGF-β1/Smad Signaling in Mice
Bin Li, Xiaochen Chi, Ying Huang, Weitong Wang, Zhuo Liu · 2024 · Frontiers in Bioscience-Landmark
Using the canine microbiome to bridge translation of cancer immunotherapy from pre-clinical murine models to human clinical trials
Kara Teresa Kleber, Khurshid R Iranpur, Lauren M. Perry, Sylvia M. Cruz, Aryana M. Razmara, William T. N. Culp, Michael Sean Kent, Jonathan A. Eisen, Robert B. Rebhun, Robert J. Canter · 2022 · Frontiers in Immunology
Second primary cancer among 217702 colorectal cancer survivors: An analysis of national German cancer registry data
Linda A. Liang, Ying‐Ju Tseng, Luana Fiengo Tanaka, Stefanie J. Klug · 2023 · International Journal of Cancer
Antibiotic-Induced Dysbiosis of the Gut Microbiota Impairs Gene Expression in Gut-Liver Axis of Mice
Pu Liu, Yv Zhang, Zhongyuan Zhang, Xiaorong Huang, Xiaojie Su, Shilong Yang, Yongfang Xie · 2023 · Genes
Perspective on the Role of Gut Microbiome in the Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors
Ludovico Abenavoli, Michele Montori, Gianluca Svegliati‐Baroni, Maria Eva Argenziano, Francesca Giorgi, Giuseppe Guido Maria Scarlata, Francesca Romana Ponziani, Emidio Scarpellini · 2023 · Medicina
Longitudinal gut fungal alterations and potential fungal biomarkers for the progression of primary liver disease
Shiman Jiang, Lvwan Xu, Yanfei Chen, Zheyue Shu, Longxian Lv, Yuxi Zhao, Kefan Bi, Sisi Yang, Qiangqiang Wang, Lanjuan Li · 2024 · Science China Life Sciences
Involvement of CircRNAs in regulating The “New Generation of Cancer Hallmarks”: A Special Depiction on Hepatocellular Carcinoma
Alyaa Dawoud, R.A. Elmasri, A.H. Mohamed, A. Mahmoud, Monica Mosaad Rostom, Rana Ahmed Youness · 2024 · Critical Reviews in Oncology/Hematology
When human cells meet bacteria: precision medicine for cancers using the microbiota.
Han Zhang, Litao Sun · 2018 · Europe PMC (PubMed Central)
Lipopeptide(s) associated with human microbiome as potent cancer drug
Vivek Chauhan, Shamsher S. Kanwar · 2020 · Seminars in Cancer Biology
Molecular mechanisms of oncogene-induced inflammation and inflammation-sustained oncogene activation in gastrointestinal tumors: An underappreciated symbiotic relationship
Denada Dibra, Lopa Mishra, Shulin Li · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Beyond liver fibrosis: Hepatic stellate cell senescence links obesity to liver cancer by way of the microbiome
Nicholas Adam Shackel, Mathew Alexander Vadas, Jennifer R. Gamble, Geoffrey William McCaughan · 2013 · Hepatology
Bacterial Translocation and Risk of Liver Cancer in a Finnish Cohort
Baiyu Yang, Jessica L. Petrick, Jake E. Thistle, Lígia A. Pinto, Troy J. Kemp, Hao Quang Tran, Andrew T. Gewirtz, Tim Waterboer, Veronika Fedirko, Mazda Jenab et al. · 2019 · Cancer Epidemiology Biomarkers & Prevention
pir-hsa-216911 inhibit pyroptosis in hepatocellular carcinoma by suppressing TLR4 initiated GSDMD activation
Zhouxiang Liao, Lichao Yang, Xiaojing Cheng, Xuejing Huang, Qi Zhang, Daoqiang Wen, Zhenyu Song, Yasi Li, Sha Wen, Yongfeng Li et al. · 2025 · Cell Death Discovery
Gram-negative intratumoral bacteria mediate lymph node metastasis through LPS-TLR4/MAPK signaling pathway in cervical cancer
Yaqin Liu, Peng Ma, Dongdong Liu, Yongzhu Liu, Ziwei Ran, Lunhao Yang, Lingqing Xu, Weiguo Yin, Chen Fu, Linhai Li et al. · 2025 · Journal of Infection
Regulatory Role and Biomarker Potential of Gut Microbiota Metabolites in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease to Hepatocellular Carcinoma
Zongyuan Che, Wei Xue, Xuchen Zhao, Congzhong Hu, Yanzhang Tian · 2025 · Clinical and Translational Gastroenterology
Chronic stress drives liver cancer by impairing the hepatic kynurenine pathway and immune surveillance
Renhui Sun, Deyan Jiao, Wenjing Yuan, Hao Wang, Lingtong Ren, Zhendong Fu, Jiaxuan Zhang, Xuetian Yue, Zhuanchang Wu, Chunyang Li et al. · 2026 · Nature Metabolism
Pathogenesis of Hepatocellular Carcinoma Development in Non-alcoholic Fatty Liver Disease
Kirti Shetty, Jian Chen, Ji‐Hyun Shin, Wilma SR Jogunoori, Lopa Mishra · 2015 · Current Hepatology Reports
Impact of Maternal Obesity on Liver Disease in the Offspring: A Comprehensive Transcriptomic Analysis and Confirmation of Results in a Murine Model
Beat Moeckli, Vaihere Delaune, Julien Prados, Matthieu Tihy, Andrea Peloso, Graziano Oldani, Thomas Delmi, Florence Slits, Quentin Gex, Laura Rubbia‐Brandt et al. · 2022 · Biomedicines
Enterobacteria impair host p53 tumor suppressor activity through mRNA destabilization
Marie‐Stéphanie Aschtgen, Konstantinos Fragkoulis, Gema Sanz, Staffan J. Normark, Galina Selivanova, Birgitta Henriques‐Normark, Sylvain Peuget · 2022 · Oncogene
Biejiajian pill inhibits progression of hepatocellular carcinoma by downregulating PDGFRβ signaling in cancer-associated fibroblasts
Weicong Chen, Xuemei Yang, Jialing Sun, Yuyao Chen, Wenting Zhao, Chunyu He, Haiyan An, Jie Pang, Wei Xu, Bin Wen et al. · 2022 · Journal of Ethnopharmacology
DNA Damage and the Gut Microbiome: From Mechanisms to Disease Outcomes
Yun-Chung Hsiao, Chih‐Wei Liu, Yifei Yang, Jiahao Feng, Haoduo Zhao, Kun Lü · 2023 · DNA
Hepatic stellate cell stearoyl co-A desaturase activates leukotriene B4 receptor 2 - β-catenin cascade to promote liver tumorigenesis
Sonal Sinha, Satoka Aizawa, Yasuhiro Nakano, Alexander Rialdi, Hye Yeon Choi, Rajan Shrestha, Stephanie Q. Pan, Yibu Chen, Meng Li, Audrey Kapelanski‐Lamoureux et al. · 2023 · Nature Communications
Characterization of disease-associated microbiota in hepatocellular carcinoma
Pengfei Sun, Zhongchao Li, Bo Zhang · 2023 · Journal of Cancer Research and Therapeutics
Effects of metronidazole on colorectal cancer occurrence and colorectal cancer liver metastases by regulating Fusobacterium nucleatum in mice
Maijian Wang, Yong Li, Xuefeng Yang, Zhenxing Liu, Kai Wang, Dengmei Gong, Jida Li · 2023 · Immunity Inflammation and Disease
Recent advances in different interactions between toll-like receptors and hepatitis B infection: a review
Saeed Soleiman-Meigooni, Aref Yarahmadi, Amir Hossein Kheirkhah, Hamed Afkhami · 2024 · Frontiers in Immunology
The microbiome: a link between obesity and breast cancer risk
Mohamed Kadry Gaber, Alana A. Arnone, Pierre‐Alexandre Vidi, Katherine Loree Cook · 2024 · Frontiers in Microbiomes
Sophocarpine attenuates toll‐like receptor 4 in steatotic hepatocytes to suppress pro‐inflammatory cytokines synthesis
Chunyan Song, Xin Ying Zeng, Yang Wang, Jian Gang Shi, Hui Qian, Yi Zhang, Jia‐Qing Fang, Xia Sheng, Jianming Zheng, Yue-Xiang Chen · 2014 · Journal of Gastroenterology and Hepatology
Phorbol ester-induced neutrophilic inflammatory responses selectively promote metastatic spread of melanoma in a TLR4-dependent manner
Tobias Bald, Jennifer Landsberg, Philipp Jansen, Evelyn Gaffal, Thomas Tüting · 2015 · OncoImmunology
CD24–p53 axis suppresses diethylnitrosamine-induced hepatocellular carcinogenesis by sustaining intrahepatic macrophages
Dongling Li, Minling Hu, Ying Liu, Peishuang Du, Peishuang Du, Chi-Shan Li, Liang Cheng, Ping Liu, Jing Jiang, Lishan Su et al. · 2018 · Cell Discovery
Kansuiphorin C and Kansuinin A ameliorate malignant ascites by modulating gut microbiota and related metabolic functions
Yi Zhang, Jian-Wei Lou, Kang An, Qiao Zhang, Shi-Kang Zhou, Beihua Bao, Yudan Cao, Weifeng Yao, Yuping Tang, Li Zhang · 2019 · Journal of Ethnopharmacology
The Human Microbiomes in Pancreatic Cancer: Towards Evidence-Based Manipulation Strategies?
Giovanni Brandi, Silvia Turroni, Florencia M. McAllister, Giorgio Frega · 2021 · International Journal of Molecular Sciences
Toll-like receptors in hepatocellular carcinoma: potential novel targets for pharmacological intervention
Hai Zou, Wu-Ke Wang, Yanlong Liu, Martin Braddock, Ming‐Hua Zheng, Dongsheng Huang · 2016 · Expert Opinion on Therapeutic Targets
Hallmarks of liver cancer: Therapeutic implications
Josep Maria Llovet, Roser Pinyol, Silvia Affò, Mark M. Yarchoan, Gregory James Gores, Robin Kate Kelley, Scott W. Lowe, Daniela Sia, Augusto Villanueva · 2026 · Cell
Spermine is an endogenous iron chelator that inhibits ferroptosis
Man Li, Xuexin Yu, Shuqin Ouyang, Xiaohong Chen, Huiqi Yu, Yuanji Liu, Ziwen Li, Chunhua Yu, Rui Kang, Christine Gaillet et al. · 2026 · Nature
Association of Chronic Opisthorchis Infestation and Microbiota Alteration on Tumorigenesis in Cholangiocarcinoma
Thanika Ketpueak, Parameth Thiennimitr, Nattayaporn Apaijai, Siriporn Chaisin Chattipakorn, Nipon Chattipakorn · 2020 · Clinical and Translational Gastroenterology
Dietary Patterns and Associated Microbiome Changes that Promote Oncogenesis
Shakhzada Ibragimova, Revathy Ramachandran, Fahad R. Ali, Leonard Lipovich, Samuel B. Ho · 2021 · Frontiers in Cell and Developmental Biology
Multi-Omics Analyses Identify Signatures in Patients with Liver Cirrhosis and Hepatocellular Carcinoma
Ming‐Wei Lai, Yu‐De Chu, Chao‐Wei Hsu, Yi‐Cheng Chen, Kung‐Hao Liang, Chau‐Ting Yeh · 2022 · Cancers
Unraveling the intricate relationship: Influence of microbiome on the host immune system in carcinogenesis
Saksham Garg, Nikita Sharma, Bharmjeet, Asmita Das · 2023 · Cancer Reports
Polyphenolic Compounds: Orchestrating Intestinal Microbiota Harmony during Aging
Quélita Cristina Pereira, Isabela Monique Fortunato, Fabrício de Sousa Oliveira, Marisa Claudia Alvarez, Tanila Wood dos Santos, Marcelo Lima Ribeiro · 2024 · Nutrients
Resistance to Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma (HCC): Clinical Implications and Potential Strategies to Overcome the Resistance
Ali Gawi Ermi, Devanand Sarkar · 2024 · Cancers
Experimental Models for Preclinical Research in Hepatocellular Carcinoma
Pedro Molina-Sánchez, Amaia Lujambio · 2019 · Molecular and translational medicine
Review of nutritional status, body composition, and effects of antineoplastic drug disposition
John T. Wiernikowski, Melanie Brooke Bernhardt · 2020 · Pediatric Blood & Cancer
The impact of the gut microbiome on liver transplantation
Nikki K. Duong, Jasmohan Singh Bajaj · 2021 · Current Opinion in Organ Transplantation
Research progress of gut microbiota in hepatocellular carcinoma
Keliu Li, Jianhua Liu, Xiaosong Qin · 2022 · Journal of Clinical Laboratory Analysis
The Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver Disease
M. Arias, Emilio Fábrega, Marcos López‐Hoyos, Javier Crespo · 2015 · BioMed Research International
Who determines the outcomes of HBV exposure?
Baohong Wang, Lanjuan Li · 2015 · Trends in Microbiology
Alcohol, TLR4-TGF-β antagonism, and liver cancer
Hidekazu Tsukamoto, Lopa Mishra, Keigo Machida · 2013 · Hepatology International
The Gut Microbiome and Its Multifaceted Role in Cancer Metabolism, Initiation, and Progression: Insights and Therapeutic Implications
Kai Xu, Zainab Yusufali Motiwala, Irene Corona‐Avila, Dhruvi Makhanasa, Leen Alkahalifeh, Md. Wasim Khan · 2025 · Technology in Cancer Research & Treatment
Insights into the gut-liver axis: mechanisms and emerging therapies in hepatocellular carcinoma
Yongjian Hu, Mingming Gao, Jiajin Chenghuang, Rui Bao · 2025 · Frontiers in Pharmacology
Identification of a brand intratumor microbiome signature for predicting prognosis of hepatocellular carcinoma
Yisu Song, Ze Xiang, Zhengyang Lu, Renyi Su, Wenzhi Shu, Meihua Sui, Xuyong Wei, Xiao Xu · 2023 · Journal of Cancer Research and Clinical Oncology
Mitochondrial GCN5L1 acts as a novel regulator for iron homeostasis to promote sorafenib sensitivity in hepatocellular carcinoma
Xiuya Hu, Peiyu Zhang, Sai Li, Jiaqi Zhang, Danni Wang, Zihan Wang, Lu Zhu, Lingdi Wang · 2024 · Journal of Translational Medicine
Ferroptosis crosstalk in anti-tumor immunotherapy: molecular mechanisms, tumor microenvironment, application prospects
Yining Lu, Xiao‐Ting Xie, Lianxiang Luo · 2024 · APOPTOSIS
Intestinal Microbiota: Unexpected Alliance with Tumor Therapy
Naofumi Mukaida · 2014 · Immunotherapy
Prognostic impact of toll-like receptors 2 and 4 expression on monocytes in Egyptian patients with hepatocellular carcinoma
Asmaa Mohamed Zahran, Zeinab Albadry M. Zahran, Omnia El‐Badawy, Mona Hussein Abdel-Rahim, Wageeh A. Ali, Amal Rayan, Muhammad Abbas El‐Masry, Mohamed A. A. Abozaid, ‏Helal F. Hetta · 2019 · Immunologic Research
Liver DCs in health and disease
Theresa Hildegard Wirtz, Elisa Fabiana Brandt, Marie‐Luise Berres · 2019 · International review of cytology